ATTO Atento S.A.
Atento S.A. (ATTO) Insider Activity
What the officers, directors and large holders did with their own shares. Only open-market purchases and sales count toward the totals — grants, option exercises and shares withheld for tax are compensation mechanics, not decisions, and they're listed separately below.
How much of that selling was preplanned? 0% planned / 100% discretionary
Largest single sale: $1.6M.
Where they traded
Last open-market purchase: August 6, 2026 .
Recent open-market activity
| Date | Insider | Role | Action | Shares | Price | Value | Held after |
|---|---|---|---|---|---|---|---|
| 5 fills | Buy | 2,188,235 | $17.00 | $37.2M | 6,154,213 | ||
| WALSH COLIN 2 fills | Director | Buy | 1,000,000 | $17.00 | $17.0M | 3,020,632 | |
| venBio Global Strategic Fund IV, L.P. | 10% Owner | Buy | 382,352 | $17.00 | $6.5M | 4,181,367 | |
| Sanofi | 10% Owner | Buy | 300,000 | $17.00 | $5.1M | 1,082,855 | |
| 46 fills | Sell | 211,614 | $21.28 | $4.5M | 84,012 −71.6% of holding | ||
| WALSH COLIN 46 fills | Director | Sell | 211,614 | $21.28 | $4.5M | 84,012 −71.6% of holding | |
| 2 fills | Buy | 170,000 | $21.00 | $3.6M | 85,000 | ||
| WALSH COLIN 2 fills | Director | Buy | 170,000 | $21.00 | $3.6M | 85,000 |
Form 4s are due within two business days of a transaction, so this is close to real time — unlike the quarterly 13F data on the Institutional tab. A single large sale often reflects a prearranged 10b5-1 plan rather than a fresh view, so read a pattern of sales rather than any one of them.